CBP-1019-102

CBP-1019-102

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Bi-Ligand-Drug Conjugate CBP-1019 in Patients with Advanced Thoracic Tumors.

Locations

Shanghai Chest Hospital


Shanghai,China

Recruiting
Zhejiang Cancer Hospital


Hangzhou,China

Recruiting
Union Hospital Tong JI Medical college Huazhong University of Science And Technology


Wuhan,China

Recruiting